Home > Drug List > Gilteritinib > Indications of Gilteritinib

Indications of Gilteritinib

Gilteritinib is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML)  with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test.

FDA,2022.01